文献速递肝病消化道肿瘤与早癌

细胞色素P450家族成员CYP39A1通过女性优先表达阻断肝细胞癌发生

Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression.
PubMed 文献 · Gut · 2022-01-07

研究利用两个肝癌队列(n=551)的转录组与代谢组数据,比较雌雄非肿瘤肝组织中861个性别相关分子,发现CYP39A1在女性肝中显著高表达且在超90%肝癌患者中骤降;功能实验表明CYP39A1通过C端区域抑制c-Myc转录激活活性,从而阻断肿瘤形成。

要点

  • 女性非肿瘤肝组织较男性显著抑制癌症相关疾病与功能,涉及861个性别相关分子。
  • CYP39A1在女性肝中显著高于男性,在超90%肝癌患者肿瘤中表达骤降。
  • 外源性CYP39A1在雌雄小鼠中均显著阻断肿瘤形成,部分缩小性别差异。

核心结论

  • CYP39A1是女性优先表达的肝特异性基因,为肝癌发生的强抑制因子。
  • 上调CYP39A1的策略未来可能成为女性和男性肝癌的治疗方法。

研究设计与样本

  • 使用两个肝癌队列(n=551)的转录组与代谢组数据进行组间比较和 ingenuity 通路分析。
  • 采用细胞实验、分子实验及多种原位肝癌小鼠模型进行功能验证。

主要发现

  • 雌性与男性肝癌患者非肿瘤肝组织间鉴定出861个性别相关分子,女性肝中癌症相关疾病与功能显著受抑制。
  • CYP39A1在女性肝中显著高于男性,在超90%肝癌患者肿瘤中表达骤降。
  • 外源性CYP39A1在雌性和雄性小鼠中均显著阻断肿瘤形成,并部分缩小肝癌发生的性别差异。
  • CYP39A1的抑癌作用不依赖其已知P450酶活性,而依赖其C端区域抑制c-Myc转录激活活性。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTS: The incidence of hepatocellular carcinoma (HCC) shows an obvious male dominance in rodents and humans. We aimed to identify the key autosomal liver-specific sex-related genes and investigate their roles in hepatocarcinogenesis. DESIGN: Two HCC cohorts (n=551) with available transcriptome and metabolome data were used. Class comparisons of omics data and ingenuity pathway analysis were performed to explore sex-related molecules and their associated functions. Functional assays were employed to investigate roles of the key candidates, including cellular assays, molecular assays and multiple orthotopic HCC mouse models. RESULTS: A global comparison of multiple omics data revealed 861 sex-related molecules in non-tumour liver tissues between female and male HCC patients, which denoted a significant suppression of cancer-related diseases and functions in female liver than male. A member of cytochrome P450 family, CYP39A1, was one of the top liver-specific candidates with significantly higher levels in female vs male liver. In HCC tumours, CYP39A1 expression was dramatically reduced in over 90% HCC patients. Exogenous CYP39A1 significantly blocked tumour formation in both female and male mice and partially reduced the sex disparity of hepatocarcinogenesis. The HCC suppressor role of CYP39A1 did not rely on its known P450 enzyme activity but its C-terminal region, by which CYP39A1 impeded the transcriptional activation activity of c-Myc, leading to a significant inhibition of hepatocarcinogenesis. CONCLUSIONS: The liver-specific CYP39A1 with female-preferential expression was a strong suppressor of HCC development. Strategies to up-regulate CYP39A1 might be promising methods for HCC treatment in both women and men in future.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Ji F, Zhang J, Liu N, et al. Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression. Gut. 2022. PMID: 34996827. doi:10.1136/gutjnl-2021-326050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。